Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Coagulation
Scientists at University Hospital, Department of Urology detail research in coagulation
April 16th, 2007
New investigation results, "Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation," are detailed in a study published in European Urology. According to recent research from Basel, Switzerland, "Ongoing oral anticoagulation (OA) contraindicates transurethral electroresection of the prostate. We evaluated the safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing OA with coumarin derivatives, aspirin, or clopidogrel, complaining of symptomatic benign prostatic hyperplasia (BPH)." "We evaluated perioperative parameters, functional outcome, and adverse...
Source: Hematology Week (2007-04-16)
|
